Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50
Published December 22, 2021 · Recall initiated: October 12, 2021
Summary
FDA records drug Class II recall D-0281-2022, published December 22, 2021 and initiated October 12, 2021. Recalling firm: Teligent Pharma, Inc.; Status: Terminated; Reported quantity: 14,664 glass bottles; Lot: Lot #: 13058, Exp. date 02/2022 and 13768, Exp. date 05/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Teligent Pharma, Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 13058, Exp. date 02/2022 and 13768, Exp. date 05/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATriamcinolone Acetonide Cream USP, 0.1%, packaged in a) 15 grams tubes, NDC 52565-056-15; b) 30 grams tubes,March 30, 2022
- FDADesoximetasone Ointment USP, 0.25%, packaged in a) 100 grams tubes, NDC 52565-030-99; b) 60 grams tubes, NDCMarch 30, 2022
- FDATriamcinolone Acetonide Ointment USP, 0.5%, Net Wt. 15 grams tube, Rx Only, Teligent Pharma, Inc., Buena, NewMarch 30, 2022
- FDALidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 Oz) tube, Rx Only, Manufactured for: Hi-Tech Pharmacal Co.,March 30, 2022
- FDALidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent PharmaDecember 22, 2021
- FDAMethylcobalamin 12mg/ml injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MDDecember 22, 2021
Questions about this recall
Was Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50 recalled?
Yes. FDA published recall D-0281-2022 on December 22, 2021. Reported hazard: CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release